Molly B. Schmid, Ph.D. is the President of the Inland Empire network of the Tech Coast Angels, a member of the TCA Board of Directors, and a a Senior Counselor for TriTech Small Business Development Center. She has had a distinguished career in academia, where she was Professor and Entrepreneur-in-Residence at Keck Graduate Institute of Applied Life Sciences in Claremont CA, and was previously an Assistant Professor of Molecular Biology at Princeton University.
She has also held senior leadership positions in the biotech industry, where she served as Senior Vice President of Preclinical Programs at Affinium Pharmaceuticals in Toronto, Director of Genomics and Bioinformatics at Genencor International, and Director of Biology and Vice President of Research Alliances at Microcide Pharmaceuticals. In these companies, she was part of executive teams that raised over $100MM in funding through venture capital, corporate partnerships, public markets, and US and Canadian federal research grants. She has been honored for her achievements as a Fellow of the American Academy of Microbiology, a Searle Scholar, and a Damon-Runyon Fellow. She has nine issued U.S. patents, and several others pending.